3.49
price up icon2.35%   0.08
after-market Dopo l'orario di chiusura: 3.49
loading
Precedente Chiudi:
$3.41
Aprire:
$3.47
Volume 24 ore:
1.62M
Relative Volume:
0.57
Capitalizzazione di mercato:
$942.27M
Reddito:
-
Utile/perdita netta:
$-244.17M
Rapporto P/E:
-3.5747
EPS:
-0.9763
Flusso di cassa netto:
$-144.77M
1 W Prestazione:
+4.18%
1M Prestazione:
+9.06%
6M Prestazione:
-14.46%
1 anno Prestazione:
+86.63%
Intervallo 1D:
Value
$3.37
$3.56
Intervallo di 1 settimana:
Value
$3.045
$3.56
Portata 52W:
Value
$1.60
$6.55

Sana Biotechnology Inc Stock (SANA) Company Profile

Name
Nome
Sana Biotechnology Inc
Name
Telefono
(206) 701-7914
Name
Indirizzo
188 EAST BLAINE STREET, SUITE 350, SEATTLE
Name
Dipendente
142
Name
Cinguettio
Name
Prossima data di guadagno
2026-05-14
Name
Ultimi documenti SEC
Name
SANA's Discussions on Twitter

Compare SANA vs VRTX, REGN, ARGX, ALNY, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
SANA icon
SANA
Sana Biotechnology Inc
3.49 920.67M 0 -244.17M -144.77M -0.9763
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 109.34B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 74.35B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 50.44B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 39.78B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.02B 5.36B 287.73M 924.18M 2.5229

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-24 Iniziato Wedbush Outperform
2025-07-03 Ripresa Morgan Stanley Overweight
2025-03-18 Aggiornamento Citizens JMP Mkt Perform → Mkt Outperform
2025-03-14 Iniziato Jefferies Buy
2025-01-08 Aggiornamento TD Cowen Hold → Buy
2024-11-05 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2024-06-26 Iniziato Rodman & Renshaw Buy
2024-01-16 Aggiornamento H.C. Wainwright Neutral → Buy
2023-09-25 Iniziato JMP Securities Mkt Outperform
2023-09-05 Iniziato Citigroup Buy
2023-08-14 Iniziato TD Cowen Market Perform
2023-05-02 Iniziato H.C. Wainwright Neutral
2021-03-01 Iniziato BofA Securities Buy
2021-03-01 Iniziato Goldman Neutral
2021-03-01 Iniziato JP Morgan Neutral
2021-03-01 Iniziato Morgan Stanley Overweight
Mostra tutto

Sana Biotechnology Inc Borsa (SANA) Ultime notizie

pulisher
May 05, 2026

Sana CEO Steve Harr to give business update in May 12 webcast - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference - The Globe and Mail

May 05, 2026
pulisher
May 04, 2026

MSN Money - MSN

May 04, 2026
pulisher
May 01, 2026

SANA stock rallies 24% after hours — how much is Mayo Clinic investing in the company? - MSN

May 01, 2026
pulisher
Apr 29, 2026

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3%Time to Sell? - MarketBeat

Apr 29, 2026
pulisher
Apr 27, 2026

Sana Biotechnology abstract accepted for presentation at ASGCT By Investing.com - Investing.com India

Apr 27, 2026
pulisher
Apr 27, 2026

Sana Biotechnology to present preclinical CAR-T data at May meeting - Investing.com

Apr 27, 2026
pulisher
Apr 27, 2026

Sana Biotechnology abstract accepted for presentation at ASGCT - Investing.com

Apr 27, 2026
pulisher
Apr 27, 2026

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting - ChartMill

Apr 27, 2026
pulisher
Apr 27, 2026

Sana Biotech surges as Eric Jackson calls it a 100-bagger - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes - Yahoo Finance

Apr 27, 2026
pulisher
Apr 26, 2026

Sana Biotech rises as Mayo Clinic partners for diabetes therapy - MSN

Apr 26, 2026
pulisher
Apr 26, 2026

Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN

Apr 26, 2026
pulisher
Apr 25, 2026

Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell - MarketBeat

Apr 25, 2026
pulisher
Apr 24, 2026

Sana Biotechnology, Inc. ($SANA) President, CEO, and Director 2025 Pay Revealed - Quiver Quantitative

Apr 24, 2026
pulisher
Apr 24, 2026

Sana Biotechnology, Inc. Files Form 8-K Current Report with SEC – Key Company Information and Details - Minichart

Apr 24, 2026
pulisher
Apr 24, 2026

Sana Biotechnology | DEFA14A: Others - Moomoo

Apr 24, 2026
pulisher
Apr 24, 2026

Sana Biotechnology reclassifies board member to balance director classes By Investing.com - Investing.com Australia

Apr 24, 2026
pulisher
Apr 24, 2026

Sana Biotechnology Rebalances Board Classes With Director Shift - TipRanks

Apr 24, 2026
pulisher
Apr 24, 2026

Sana Biotechnology reclassifies board member to balance director classes - Investing.com UK

Apr 24, 2026
pulisher
Apr 24, 2026

Sana Biotechnology | DEF 14A: Definitive information statements - Moomoo

Apr 24, 2026
pulisher
Apr 24, 2026

Sana Biotechnology (SANA) details 2026 virtual meeting, board elections and EY ratification - Stock Titan

Apr 24, 2026
pulisher
Apr 23, 2026

Sana Biotechnology (SANA) Is Up 6.3% After Mayo-Backed SC451 Diabetes Cell Therapy CollaborationWhat's Changed - Sahm

Apr 23, 2026
pulisher
Apr 23, 2026

Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity Investment - Yahoo Finance

Apr 23, 2026
pulisher
Apr 23, 2026

Sana Biotechnology (SANA) Trading Range | Q4 2025: Earnings Fall ShortCommunity Sell Signals - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026
pulisher
Apr 23, 2026

Sana Biotechnology (SANA) Stock Stock Dividend (Grinds Lower) 2026-04-22Popular Trader Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 23, 2026
pulisher
Apr 22, 2026

Sana Biotechnology (SANA) Valuation Check After Mayo Clinic SC451 Collaboration And Recent Share Price Swing - Sahm

Apr 22, 2026
pulisher
Apr 22, 2026

Sana Biotechnology Partners with Mayo Clinic for Diabetes Research - HarianBasis.co

Apr 22, 2026
pulisher
Apr 22, 2026

Sana Biotechnology | 8-K: Current report - Moomoo

Apr 22, 2026
pulisher
Apr 20, 2026

Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6 - Insider Monkey

Apr 20, 2026
pulisher
Apr 20, 2026

Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7%What's Next? - MarketBeat

Apr 20, 2026
pulisher
Apr 19, 2026

10 Stocks Under $5 with Huge Upside Potential - Insider Monkey

Apr 19, 2026
pulisher
Apr 18, 2026

Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 18, 2026
pulisher
Apr 18, 2026

SANA Should I Buy - Intellectia AI

Apr 18, 2026
pulisher
Apr 17, 2026

Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race - Benzinga

Apr 17, 2026
pulisher
Apr 17, 2026

Sana Biotechnology, Inc. (SANA) Stock Analysis: A Promising 147% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Apr 17, 2026

Sana Biotechnology Inc Azioni (SANA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):